Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

IPI-926 reduces tumor growth in vivo and advances through clinical development

April 4, 2011

Superoxide dismutase [Cu-Zn] as a biomarker for drug-induced liver injury

April 4, 2011

Immunohistochemical quantitation of LAMP-2 for the diagnosis of phospholipidosis

April 4, 2011

Liver-targeted SCD inhibitor from Merck & Co. shows improved tolerability

April 1, 2011

Astellas Pharma discloses potent, orally bioavailable TRPV1 antagonists

April 1, 2011

N30 Pharma's GSNOR inhibitors show promise for the treatment of asthma

April 1, 2011

Omalizumab data in food allergy, urticaria, atopic dermatitis and geriatric asthma reported

April 1, 2011

OriBase Pharma identifies agent for BCR/ABL T315I mutant CML

March 31, 2011

New dual LFA-1/MAC-1 antagonists presented by Roche at the ACS meeting

March 31, 2011

Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes

March 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.